Matsuo Ogawa

1.1k total citations
19 papers, 855 citations indexed

About

Matsuo Ogawa is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Matsuo Ogawa has authored 19 papers receiving a total of 855 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cellular and Molecular Neuroscience, 8 papers in Molecular Biology and 6 papers in Neurology. Recurrent topics in Matsuo Ogawa's work include Nerve injury and regeneration (7 papers), Virus-based gene therapy research (5 papers) and Metabolism and Genetic Disorders (4 papers). Matsuo Ogawa is often cited by papers focused on Nerve injury and regeneration (7 papers), Virus-based gene therapy research (5 papers) and Metabolism and Genetic Disorders (4 papers). Matsuo Ogawa collaborates with scholars based in Japan. Matsuo Ogawa's co-authors include Mitsuo Yoshida, Ken‐ichi Ogura, Masasuke Araki, Ikuko Nagatsu, Kunihiko Ikeguchi, Imaharu Nakano, Toshiharu Nagatsu, Mitsuo Yoshida, Kenji Niijima and Hiroshi Ichinose and has published in prestigious journals such as Neuron, Brain Research and Experimental Neurology.

In The Last Decade

Matsuo Ogawa

19 papers receiving 835 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matsuo Ogawa Japan 12 433 326 241 215 190 19 855
Małgorzata Kohutnicka Poland 8 689 1.6× 382 1.2× 558 2.3× 622 2.9× 212 1.1× 10 1.4k
Ora Dillon‐Carter United States 15 373 0.9× 405 1.2× 148 0.6× 94 0.4× 41 0.2× 22 833
Olga Yarygina United States 14 499 1.2× 424 1.3× 109 0.5× 351 1.6× 85 0.4× 18 1.2k
Yoichi Kushima Japan 13 354 0.8× 403 1.2× 218 0.9× 57 0.3× 53 0.3× 19 900
Yasuhiro Kawamoto Japan 20 486 1.1× 469 1.4× 263 1.1× 522 2.4× 47 0.2× 46 1.3k
Mar Puigdellívol Spain 17 387 0.9× 488 1.5× 342 1.4× 158 0.7× 64 0.3× 22 978
Xavier Xifró Spain 22 635 1.5× 638 2.0× 96 0.4× 284 1.3× 88 0.5× 36 1.1k
Cristina Roseti Italy 17 477 1.1× 322 1.0× 146 0.6× 122 0.6× 77 0.4× 26 867
Yanqing Yin China 15 260 0.6× 478 1.5× 304 1.3× 151 0.7× 42 0.2× 27 969
Rita Pepponi Italy 21 438 1.0× 499 1.5× 155 0.6× 110 0.5× 46 0.2× 46 1.1k

Countries citing papers authored by Matsuo Ogawa

Since Specialization
Citations

This map shows the geographic impact of Matsuo Ogawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matsuo Ogawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matsuo Ogawa more than expected).

Fields of papers citing papers by Matsuo Ogawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matsuo Ogawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matsuo Ogawa. The network helps show where Matsuo Ogawa may publish in the future.

Co-authorship network of co-authors of Matsuo Ogawa

This figure shows the co-authorship network connecting the top 25 collaborators of Matsuo Ogawa. A scholar is included among the top collaborators of Matsuo Ogawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matsuo Ogawa. Matsuo Ogawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Koh, Kishin, Haruo Shimazaki, Matsuo Ogawa, & Yoshihisa Takiyama. (2022). A heterozygous GRID2 mutation in autosomal dominant cerebellar ataxia. Human Genome Variation. 9(1). 27–27. 2 indexed citations
2.
Ozawa, K, Yan‐Qin Shen, Shin‐ichi Muramatsu, et al.. (2000). Gene therapy of Parkinson’s disease using Adeno-Associated Virus (AAV) vectors. PubMed. 181–191. 17 indexed citations
3.
Shen, Yang, Shin‐ichi Muramatsu, Kunihiko Ikeguchi, et al.. (2000). Triple Transduction with Adeno-Associated Virus Vectors Expressing Tyrosine Hydroxylase, Aromatic-L-Amino-Acid Decarboxylase, and GTP Cyclohydrolase I for Gene Therapy of Parkinson's Disease. Human Gene Therapy. 11(11). 1509–1519. 150 indexed citations
4.
Amemiya, Morimasa, Yuko Hayashi, Matsuo Ogawa, et al.. (1999). Treatment with Steroids and Double Filtration Plasmapheresis for a Case of Anti‐GQ1b Antibody‐Positive Bickerstaff's Encephalitis. Therapeutic Apheresis. 3(1). 72–74. 7 indexed citations
5.
6.
Mogi, Makio, Akifumi Togari, Matsuo Ogawa, et al.. (1998). Effects of repeated systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to mice on interleukin-1β and nerve growth factor in the striatum. Neuroscience Letters. 250(1). 25–28. 58 indexed citations
7.
Fan, Dongsheng, Matsuo Ogawa, Kunihiko Ikeguchi, et al.. (1998). Prevention of dopaminergic neuron death by adeno-associated virus vector-mediated GDNF gene transfer in rat mesencephalic cells in vitro. Neuroscience Letters. 248(1). 61–64. 25 indexed citations
8.
9.
Kotake, Yaichiro, Mitsuo Yoshida, Matsuo Ogawa, et al.. (1996). Chronic administration of 1-benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous amine in the brain, induces parkinsonism in a primate. Neuroscience Letters. 217(1). 69–71. 51 indexed citations
10.
Ohye, Tamae, Hiroshi Ichinose, Matsuo Ogawa, Masatoshi Yoshida, & Toshiharu Nagatsu. (1995). Alterations in Multiple Tyrosine Hydroxylase mRNAs in the Substantia Nigra, Locus Coeruleus and Adrenal Gland of MPTP-treated Parkinsonian Monkeys. PubMed. 4(1). 81–85. 10 indexed citations
11.
Ogura, Ken‐ichi, Matsuo Ogawa, & Mitsuo Yoshida. (1994). Effects of ageing on microglia in the normal rat brain: immunohistochemical observations. Neuroreport. 5(10). 1224–1226. 151 indexed citations
12.
Yoshida, Masaki, Matsuo Ogawa, Kenichi Suzuki, & T Nagatsu. (1993). Parkinsonism produced by tetrahydroisoquinoline (TIQ) or the analogues.. PubMed. 60. 207–11. 20 indexed citations
13.
Ogawa, Matsuo, Masasuke Araki, Makoto Naito, et al.. (1993). Early changes of macrophage-like immunoreactivity in the rat inferior olive after intraperitoneal 3-acetylpyridine injection. Brain Research. 610(1). 135–140. 13 indexed citations
14.
Niijima, Kenji, Masasuke Araki, Matsuo Ogawa, et al.. (1990). Enhanced survival of cultured dopamine neurons by treatment with soluble extracts from chemically deafferentiated striatum of adult rat brain. Brain Research. 528(1). 151–154. 38 indexed citations
15.
Niijima, Kenji, Tatsuhide Kunishita, Masatoyo Nishizawa, et al.. (1990). Interleukin 3 as a trophic factor for central cholinergic neurons in vitro and in vivo. Neuron. 4(3). 429–436. 147 indexed citations
16.
Fujimoto, Ken’ichi, Mitsuo Yoshida, Kunihiko Ikeguchi, & Matsuo Ogawa. (1990). Impairment of Passive and Active Avoidance Produced by Destruction of the Cholinergic Projection from the Pedunculopontine Nucleus to the Medial Thalamus of the Rat. Dementia and Geriatric Cognitive Disorders. 1(2). 65–73. 7 indexed citations
17.
Ogawa, Matsuo, Masasuke Araki, Ikuko Nagatsu, & Mitsuo Yoshida. (1989). Astroglial cell alteration caused by neurotoxins: Immunohistochemical observations with antibodies to glial fibrillary acidic protein, laminin, and tyrosine hydroxylase. Experimental Neurology. 106(2). 187–196. 42 indexed citations
18.
Okada, Koji, Toshikazu Saito, San‐e Ishikawa, et al.. (1987). A case of erythropoietic protoporphyria with neural and abdominal symptoms.. Nihon Naika Gakkai Zasshi. 76(4). 553–557. 1 indexed citations
19.
Ogawa, Matsuo, et al.. (1976). [Quantitative studies of neurons of the substantia nigra and basal ganglia in parkinsonism].. PubMed. 16(4). 311–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Małgorzata Kohutnicka Breakdown of academic impact, for papers by Ora Dillon‐Carter Breakdown of academic impact, for papers by Olga Yarygina Breakdown of academic impact, for papers by Yoichi Kushima Breakdown of academic impact, for papers by Yasuhiro Kawamoto Breakdown of academic impact, for papers by Mar Puigdellívol Breakdown of academic impact, for papers by Xavier Xifró Breakdown of academic impact, for papers by Cristina Roseti Breakdown of academic impact, for papers by Yanqing Yin Breakdown of academic impact, for papers by Rita Pepponi
Rankless by CCL
2026